What does dextromethorphan do, including its mechanism of action, recommended dosing, contraindications, and side effects?

Dextromethorphan: Mechanism, Dosing, and Clinical Considerations

Dextromethorphan is a non-sedating cough suppressant that works by centrally modulating the cough reflex in the brainstem, with proven efficacy for acute cough at 60 mg doses, though commonly available over-the-counter preparations contain subtherapeutic amounts. 1

Mechanism of Action

Dextromethorphan functions through multiple pharmacological pathways:

• Primary antitussive action: Acts as a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist that suppresses the cough reflex centrally in the brainstem 2, 3
• Metabolic pathway: Undergoes O-demethylation via CYP2D6 to produce dextrorphan (DXO), its major active metabolite, followed by N-demethylation to 3-hydroxymorphinan 4
• Additional mechanisms: Exhibits diverse pharmacologic actions in the central nervous system beyond cough suppression, including effects on glutamatergic signaling 3, 5

Recommended Dosing

For Cough Suppression

The therapeutic dose for maximum cough reflex suppression is 60 mg, which is significantly higher than most over-the-counter preparations provide. 1

Standard FDA-approved dosing for extended-release formulations 6:

• Adults and children ≥12 years: 10 mL (equivalent to 30 mg dextromethorphan hydrobromide) every 12 hours, not exceeding 20 mL in 24 hours
• Children 6 to <12 years: 5 mL every 12 hours, not exceeding 10 mL in 24 hours
• Children 4 to <6 years: 2.5 mL every 12 hours, not exceeding 5 mL in 24 hours
• Children <4 years: Do not use 6

Important Dosing Considerations

• The generally recommended over-the-counter dosage is likely subtherapeutic for optimal cough suppression 1
• Maximum cough reflex suppression occurs at 60 mg and can be prolonged 1
• Critical warning: Exercise caution when recommending higher doses, as many combination preparations contain additional ingredients such as paracetamol (acetaminophen) that could reach toxic levels 1

Contraindications and Precautions

Age-Related Contraindications

• Absolutely contraindicated in children under 4 years of age 6
• Severe neurotoxicity risk in young children: Dextromethorphan toxicity in children ≤4 years can cause dextromethorphan-associated neurotoxicity with cerebellar edema (DANCE), characterized by cytotoxic edema in cerebellar hemispheres and profound neurological compromise 7

Drug Interactions

• CYP2D6 interactions: Genotypic variations and drug interactions affecting CYP2D6 can cause large inter-individual variability in pharmacological and toxicological effects 4
• Bupropion inhibits CYP2D6, significantly increasing dextromethorphan plasma levels through competitive inhibition 8, 5

Allergy Considerations

• Some formulations contain sodium metabisulfite, which may cause allergic-type reactions in susceptible individuals 6

Side Effects and Safety Profile

General Safety

• Favorable safety profile: Dextromethorphan is generally well-tolerated at therapeutic doses 3, 5
• Non-sedating: Unlike codeine or pholcodine, dextromethorphan does not cause significant sedation 1
• Lower adverse effect profile: Has significantly fewer adverse effects compared to other opiate antitussives like codeine or pholcodine 1

Abuse Potential

• At higher doses, dextromethorphan causes psychoactive effects, making it appealing for abuse 4
• This abuse potential is particularly relevant given its widespread availability in over-the-counter preparations

Pediatric Toxicity

• Life-threatening in young children: Sudden unresponsiveness and cerebellar edema can occur following ingestion of cough medications containing dextromethorphan in children under 5 years 7
• Requires immediate recognition: Timely recognition and optimal management can result in good clinical outcomes despite profound initial insult 7

Clinical Efficacy Evidence

Acute Cough

• Proven efficacy: Meta-analysis demonstrates suppression of acute cough 1
• Variable efficacy in URI: Studies show conflicting results for upper respiratory infection-related cough, with some showing 40-60% suppression in chronic bronchitis/COPD but limited efficacy (<20% suppression) in URI 2

Comparative Effectiveness

• Superior to codeine/pholcodine: Codeine and pholcodine have no greater efficacy than dextromethorphan but carry a much greater adverse side effect profile and are not recommended 1
• Context-dependent efficacy: The differential effect based on pathology suggests central cough mechanisms may differ between disorders, affecting drug sensitivity 2

Common Pitfalls to Avoid

1. Underdosing: Most over-the-counter preparations contain subtherapeutic doses for optimal cough suppression 1
2. Combination product toxicity: When increasing doses, failing to account for other ingredients (especially acetaminophen) in combination products can lead to unintended toxicity 1
3. Inappropriate pediatric use: Using in children under 4 years of age can result in severe, potentially fatal neurotoxicity 6, 7
4. Overlooking drug interactions: Failing to consider CYP2D6 inhibitors or genetic variations that dramatically alter dextromethorphan metabolism 4